Saccharomyces boulardii CNCM I-745 in different clinical conditions.
- 2014-07-04
- Review
- Expert opinion on biological therapy 14(11)
- Ener Cagri Dinleyici
- Ates Kara
- Metehan Ozen
- Yvan Vandenplas
- PubMed: 24995675
- DOI: 10.1517/14712598.2014.937419
- Low evidence
Saccharomyces boulardii could be used in patients needing Helicobacter pylori eradication because the S. boulardii improves compliance, decreases the side effects and moderately increases the eradication rate.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- not specified